A proven foundation for vaccine protocols. Canine 1-DAPPv is a combination vaccine approved for protection against canine distemper virus, adenovirus type 1 and 2, canine parainfluenza virus, and canine parvovirus.
Protects against all known strains of CPV, including CPV-2c2,3
High antigenic mass (titer), low passage parvovirus vaccine
Canine vaccine containing CPV-2b, one of the most prevalent field strains of parvovirus
Protects against 2 types of adenovirus that cause hepatitis and respiratory disease in dogs
Provides disease coverage for commonly spread canine viruses, distemper, adenovirus types 1 and 2, parainfluenza and parvovirus in 1 formula
First to publish data showing protection against CPV-2c challenge2
Multiple studies demonstrate the ability to override maternal antibodies1
INDICATIONS:
An aid in the prevention of disease caused by canine distemper virus, adenovirus type 1 (hepatitis) and adenovirus type 2 (respiratory disease), canine parainfluenza virus, and canine parvovirus.
Recommended for use in healthy dogs 6 weeks of age or older.
ADMINISTRATION AND DOSAGE
Subcutaneous or intramuscular injection
Primary vaccination may begin as early as 6 weeks
Repeat at 2 to 4 week intervals until the dog is 12 weeks of age
2. Larson LJ, Schultz RD. Do two current canine parvovirus type 2 and 2b vaccines provide protection against the new type 2c variant? Vet Ther. 2008;9(2):94–101.
3. Schultz RD, Thiel B, Mukhtar E, Sharp P, Larson LJ. Age and long-term protective immunity in dogs and cats. J Comp Pathol. 2010;142 Suppl 1:S102–S108.
4. Greene C, Rupprecht C. Rabies and other lyssavirus infections. In: Greene CE, ed. Infectious Diseases of the Dog and Cat. 3rd ed. St. Louis, MO: Saunders/Elsevier; 2006:167–183.
7. Cornell University College of Veterinary Medicine; American Association of Feline Practitioners. Feline leukemia virus. Available at: http://www.vet.cornell.edu/fhc/brochures/felv.html . Accessed December 29, 2011.
8. Spibey N, Greenwood NM, Sutton D, Chalmers WS, Tarpey I. Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus. Vet Microbiol. 2008;128(1-2) :48-55.